We've updated our 2019 analysis which compares the annual and lifetime treatment costs of the 10 mos...
Read moreThis research aims to understand if just three PICOs are feasible by analysing recent HTA assessment...
Read moreOur research aims to gauge awareness of the new EU HTA process within the pharmaceutical industry in...
Read moreOur study compares and contrasts the evaluation and reimbursement pathways for digital therapeutics ...
Read moreOur study aims to understand how the severity modifier has been implemented so far and its impact on...
Read moreWe outline the challenges pharma companies encounter when launching cell and gene therapies, and ass...
Read moreGermany is reshaping its Ministry of Health to prioritize the prevention of diseases like cancer, de...
Read moreDiscover the latest developments in AIFA reform as delays persist with the extension of CTS and CPR ...
Read moreFrench government's ambitious plan to save €1 billion in healthcare expenses by 2024 through new r...
Read moreLearn about the ground breaking consultation by NHS England and NICE on expanding the Antimicrobial ...
Read more